The UCLA Law Center on Reproductive Health, Law, and Policy has filed a new amicus brief in Louisiana v. FDA, prepared with colleagues at bsky.app/profile/ansi... and O'Melveny & Myers LLP on behalf of 322 reproductive health researchers: law.ucla.edu/sites/defaul...
UCLA Law Center on Repro Health, Law, & Policy
@uclarepropolicy.bsky.social
Reimagining the future of reproductive health, law, and policy in a time of urgent need. The UCLA Law CRHLP is a think tank and research center developing long-term, lasting solutions that advance all aspects of reproductive justice.
A new policy brief from CRHLP and the Mother Infant Cash Coalition examines the baseline demographics of 977 participants across four unconditional direct cash assistance programs serving pregnant and postpartum people nationwide. law.ucla.edu/sites/defaul...
Join CRHLP and Los Angeles Guild for Reproductive Health on June 11th, from 6-8pm for Community & Conversation: Reproductive Health in America! Staff Attorney Cathren Cohen will be joining for a discussion about the state of reproductive health locally and nationally. RSVP here: lnkd.in/gTHJYew9
BREAKING UPDATE: Today, the U.S. Supreme Court granted a stay of an order issued by the Fifth Circuit Court of Appeals in Louisiana v. FDA. The FDA’s current rules, which allow people to receive mifepristone by mail or pharmacy, are now in place as the case proceeds on the merits.
The Fifth Circuit's ruling in Louisiana v. FDA could eliminate mail and pharmacy access to mifepristone nationwide. @uclarepropolicy.bsky.social filed an amicus brief urging SCOTUS to reverse the decision. Here, @melissagoodman.bsky.social, CRHLP’s executive director, explains what's at stake.
UCLA Law experts shed light on the abortion pill case that is making news
The executive director from UCLA Law’s Center on Reproductive Health, Law, and Policy discusses the center's joint amicus brief in the US Supreme Court case, Louisiana v. FDA.
law.ucla.edu
Today, 360 researchers—led by CRHLP & @ansirh.bsky.social —filed an amicus brief in LA v. FDA, urging SCOTUS to follow science & reject restrictions on mifepristone. Eliminating telehealth by mail & pharmacy would ban safe care for people who need it most. Read more: law.ucla.edu/sites/defaul...
law.ucla.edu
We just filed an amicus brief in the Supreme Court on behalf of 360 repro health researchers explaining why dispensing mifepristone by mail and at pharmacies is safe and backed by science!
Today, 360 researchers—led by ANSIRH & @uclarepropolicy.bsky.social—filed an amicus brief in LA v. FDA, urging SCOTUS to follow science & reject restrictions on mifepristone. Eliminating telehealth by mail & pharmacy would ban safe care for people who need it most. www.ansirh.org/research/res...
Today, 360 researchers—led by ANSIRH & @uclarepropolicy.bsky.social—filed an amicus brief in LA v. FDA, urging SCOTUS to follow science & reject restrictions on mifepristone. Eliminating telehealth by mail & pharmacy would ban safe care for people who need it most. www.ansirh.org/research/res...
360 Leading Reproductive Health Researchers Urge Supreme Court to Reject Restrictions on Mifepristone in Louisiana v. FDA
This week, the Supreme Court of the United States temporarily restored access to medication abortion pills by mail, pausing a Fifth Circuit ruling in Louisiana v. FDA that had reinstated in-person req...
ansirh.org
As the Senate holds a hearing today amplifying anti-science rhetoric about the safety of mifepristone, it’s critical to ground this conversation in evidence rather than misinformation.
Last year, with our colleagues at @uclarepropolicy.bsky.social we sent a letter to the FDA signed by over 200 scientists. The short version? Medication abortion is safe. Time to drop the junk science and move on.
Center on Reproductive Health, Law, and Policy Reproductive Health Researchers Comment Letter to FDA
On August 27th, 2025, UCLA Center on Reproductive Health, Law, and Policy (CRHLP) and Advancing New Standards in Reproductive Health (ANSIRH) at UCSF submitted a letter on behalf of more than 260 rese...
law.ucla.edu
NEW: A majority of the North Dakota Supreme Court said the state's abortion ban was unconstitutional, but ND's rule requiring a 4-vote supermajority to strike down a law resulted in the originalist minority's view winning out. @uclarepropolicy.bsky.social's Diana Kasdan and Amanda Barrow explain:
How Originalism Revived an Abortion Ban a Majority of the North Dakota Supreme Court Held Unconstitutional
Although three of the five justices on the court concluded the ban violated state due process rights, a state rule requiring a supermajority to strike down a law means the dissenting opinion controls.
statecourtreport.org
We are excited to launch “History in Reproductive Rights Cases: A post-Dobbs Resource Hub”—a collection of legal resources showing how history can inform state constitutional cases to protect, rather than restrict, reproductive rights and gender justice. Visit the Hub: law.ucla.edu/academics/ce...
Join us on November 13th at 10 AM PT for Embryonic and Fetal Rights? What it Would Mean for Pregnant People and Reproductive Rights, Health, and Research. Don't miss out! Register now at: ucla.zoom.us/webinar/regi...
We are excited to announce an opportunity to support CRHLP! Until 12/31, every gift made will have double the impact. The Los Angeles Guild for Reproductive Health has pledged a $50k match to help sustain the work of the Center. We need your help to meet it! www.engage.ucla.edu/campaign/ucl...
We are excited to announce an opportunity to support CRHLP! Until 12/31, every gift made will have double the impact. The Los Angeles Guild for Reproductive Health has pledged a $50k match to help sustain the work of the Center. We need your help to meet it! www.engage.ucla.edu/campaign/ucl...
Join us on 11/3 at 11:30 AM PT for our upcoming webinar, Realizing the Promise of State Reproductive Freedom Amendments, featuring lawyers on the frontlines of litigation and ballot campaigns with insights into these new constitutional guarantees. RSVP: bit.ly/CRHLPReproWe...
Work with us next summer! Apply now to be a 2026 spring extern contributing to our legal and interdisciplinary work. This position is available to 2L, 3L, and LLM students at UCLA Law. Learn more: law.ucla.edu/sites/defaul.... App will be reviewed through 11/17/25.
Today, the Center on Reproductive Health, Law, and Policy at UCLA School of Law released a new report, The Promise of Reproductive Freedom Amendments: An Analysis of State Constitutional Protections and Their Impact. Read the report here: law.ucla.edu/sites/defaul...
Great supporting the annual 'Stand Up for Our Rights" fundraiser hosted by the Los Angeles Guild for Reproductive Health, benefitting @wrrapreprojustice.bsky.social, @uclarepropolicy.bsky.social, @brigidalliance.bsky.social, @powertodecide.bsky.social & @pposbc.bsky.social Los Angeles. Onward!
CRHLP has released a new report, State Abortion Policies and OB-GYN Residents: How Abortion Policies Influence Career Choices, Relocation Decisions, and Perceived Protection While Providing Care (law.ucla.edu/sites/defaul....
Today we submitted a letter with @uclarepropolicy.bsky.social to the FDA signed by over 200 scientists. The short version? Medication abortion is safe. Time to drop the junk science and move on. law.ucla.edu/reproductive...
Center on Reproductive Health, Law, and Policy Reproductive Health Researchers Comment Letter to FDA
On August 27th, 2025, UCLA Center on Reproductive Health, Law, and Policy (CRHLP) and Advancing New Standards in Reproductive Health (ANSIRH) at UCSF submitted a letter on behalf of more than 260 rese...
law.ucla.edu
Today we and our colleagues at @ansirh.bsky.social submitted a letter to the FDA for over 260 researchers affirming the 25-year safety record of mifepristone and urging the FDA not to restrict abortion pill access based on junk science. Read the letter here: law.ucla.edu/sites/defaul...
RSVP now for our Student Open House, co-hosted with @williamsinstitute.bsky.social Join us on Wednesday, September 3, 5:30–7:00 PM to meet the staff of the Williams Institute and CRHLP. Whether you’re curious about research, policy, or advocacy, now is your opportunity to get involved!
This week for our newsletter, we spotlighted our Graduate Student Researcher Monika Nayak. Monika is contributing to several of our ongoing projects, including work focused on unconditional cash transfers and reproductive health access. Read the full Q&A here: law.ucla.edu/sites/defaul...
Now we are excited to share a new online resource for our May Maternal Health Convening where you can: 📺 Watch the associated public panel 📚 Explore the readings that shaped our conversations 📌 Find new resources to share with your networks Access the webpage here: law.ucla.edu/academics/ce...
Ever wish all our newsletters were in one easy-to-find place? Have you been meaning to catch up on recent issues, but don’t know where to start? Now you can browse past issues all in one spot! law.ucla.edu/academics/ce...
Announcing our resource to stay informed on efforts to restrict or protect access to mifepristone bit.ly/CRHLPMifeTra...! The Mifepristone Litigation Tracker and Federal Action Tracker provide regularly updated info on court cases & federal admin actions that could shape abortion access nationwide
Tomorrow CRHLP Staff Attorney @cathrencohen.bsky.social will be speaking at an event hosted by Planned Parenthood. Hear from folks working in organizing, policy, education, & law. Join us in Orange County at 6:30 PM! RSVP here: www.weareplannedparenthood.org/a/looking-ba...
NEW: "Three years after Dobbs, reproductive rights litigation in state courts reveals the role of history and tradition is far from settled." @reprorights.bsky.social's Diana Kasdan and @uclarepropolicy.bsky.social's Amanda Barrow discuss how some state courts are breaking w/ SCOTUS's originalism.
The Role of History and Tradition in State Court Abortion Cases
Some state courts weighed historical evidence and found abortion rights protections, diverging from the U.S. Supreme Court’s approach in Dobbs.
statecourtreport.org